| Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica (NCT06172361) | Zhejiang University | 2024-01-20 |
| Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab (NCT06172036) | Zhejiang University | 2024-01-20 |
| Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC) (NCT06220617) | Zhejiang University | 2024-01-11 |
| Impact of Skeletal Muscle Quality and Loss on the Outcome of Liver Transplantation (NCT06188273) | Zhejiang University | 2024-01-01 |
| Artificially Intelligent Model for Accurate Detection of HCC (NCT06637059) | Zhejiang University | 2024-01-01 |
| Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer (NCT06168552) | Zhejiang University | 2023-12-15 |
| Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab (NCT06125106) | Zhejiang University | 2023-11-16 |
| Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy (NCT06082050) | Zhejiang University | 2023-11-02 |
| Intervention Study on Probiotic Combination Tableted Candy Hangover (NCT06883760) | Zhejiang University | 2023-10-17 |
| Sequences of Aerobic and Resistance Exercise and Cardio-metabolic Functions in T2D (NCT06145542) | Zhejiang University | 2023-09-25 |
| Evaluation of Consistency of PDX Model for Predicting Therapeutic Effect of Gastric Cancer (NCT05616533) | Zhejiang University | 2023-09-12 |
| Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia (NCT06027853) | Zhejiang University | 2023-09-10 |
| A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors (NCT06081322) | Zhejiang University | 2023-09-01 |
| A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors (NCT06026605) | Zhejiang University | 2023-08-25 |
| MIND Diet to Improve Cognitive Function in Mild Stroke Patients (NCT05921084) | Zhejiang University | 2023-07-23 |
| Study on Serum Metabolomics of GDM (NCT05881616) | Zhejiang University | 2023-07-18 |
| Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas (NCT05991973) | Zhejiang University | 2023-07-15 |
| Study on the Effect of Dietary Supplements on Height Improvement in Children (NCT05747560) | Zhejiang University | 2023-06-20 |
| Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome (NCT05233917) | Zhejiang University | 2023-06-09 |
| A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China (NCT05886114) | Zhejiang University | 2023-05-28 |
| Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors (NCT05976906) | Zhejiang University | 2023-05-23 |
| Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms (NCT06210230) | Zhejiang University | 2023-05-22 |
| Psychophysiological Effects of Birdsongs VS Music (NCT06581445) | Zhejiang University | 2023-05-16 |
| A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC (NCT05837052) | Zhejiang University | 2023-05-15 |
| Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus (NCT05846347) | Zhejiang University | 2023-05-15 |
| Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica (NCT05828212) | Zhejiang University | 2023-05-15 |
| LISH Trial for the Hepatic Flexure and Proximal Transverse Colon Cancer (NCT05923255) | Zhejiang University | 2023-05-14 |
| CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases (NCT05827835) | Zhejiang University | 2023-04-30 |
| UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors (NCT05848999) | Zhejiang University | 2023-04-27 |
| Psychophysiological Effects of Music (NCT06516666) | Zhejiang University | 2023-04-18 |
| Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular Carcinoma (NCT05312216) | Zhejiang University | 2023-04-01 |
| CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD (NCT05699746) | Zhejiang University | 2023-03-01 |
| Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery (NCT06164769) | Zhejiang University | 2023-03-01 |
| AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma (NCT05740891) | Zhejiang University | 2023-03-01 |
| NKG2D CAR-NK & r/rAML (NCT05734898) | Zhejiang University | 2023-03-01 |
| Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1 (NCT05593458) | Zhejiang University | 2023-03-01 |
| Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer (NCT05731726) | Zhejiang University | 2023-02-22 |
| Placement of Biliary Drainage Stent to Prevent Biliary Intestinal Anastomosis After Liver Transplantation in Children (NCT06048445) | Zhejiang University | 2023-02-07 |
| A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma (NCT05712083) | Zhejiang University | 2023-01-30 |
| Study of Comparing of With and Without Sequential Therapy of S-1 (NCT05813015) | Zhejiang University | 2023-01-28 |
| Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia (NCT05665075) | Zhejiang University | 2022-12-24 |
| Natural Killer(NK) Cell Therapy in r/r AML (NCT05665114) | Zhejiang University | 2022-12-24 |
| Prognostic Models for HCC Based on Tumor Micronecrosis (NCT05837065) | Zhejiang University | 2022-09-15 |
| Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma (NCT05907772) | Zhejiang University | 2022-08-27 |
| Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML (NCT05467254) | Zhejiang University | 2022-08-02 |
| Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML (NCT05463640) | Zhejiang University | 2022-08-02 |
| Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML (NCT05473221) | Zhejiang University | 2022-08-02 |
| Evaluate the Safety and Efficacy of CLL1 CAR-T in Patients With R/R AML (NCT05467202) | Zhejiang University | 2022-08-01 |
| HCC Staging Modified by Tumor Micronecrosis (NCT05739110) | Zhejiang University | 2022-07-15 |
| Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas (NCT05433935) | Zhejiang University | 2022-07-01 |
| A Study of BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma (NCT05430945) | Zhejiang University | 2022-06-20 |
| Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS Patients (NCT05528354) | Zhejiang University | 2022-06-02 |
| APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma (NCT04657861) | Zhejiang University | 2022-05-03 |
| Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases (NCT05325528) | Zhejiang University | 2022-04-10 |
| A Study of CAR-T Cells Targeting Both BCMA and GPRC5D in Treatment of Relapsed or Refractory Multiple Myeloma (NCT05325801) | Zhejiang University | 2022-04-01 |
| Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With R/R B-ALL (NCT05350787) | Zhejiang University | 2022-03-18 |
| Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy (NCT05349266) | Zhejiang University | 2022-03-18 |
| Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With MRD+ B-ALL (NCT05350852) | Zhejiang University | 2022-03-18 |
| Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC Patients (NCT05213221) | Zhejiang University | 2022-03-14 |
| Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer (NCT05162118) | Zhejiang University | 2022-03-08 |
| Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases (NCT05239702) | Zhejiang University | 2022-02-28 |
| Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies (NCT05239689) | Zhejiang University | 2022-02-28 |
| Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological Malignancies (NCT05252572) | Zhejiang University | 2022-02-28 |
| Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma (NCT05239676) | Zhejiang University | 2022-02-28 |
| A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma (NCT05155189) | Zhejiang University | 2022-02-21 |
| An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma (NCT05208853) | Zhejiang University | 2022-02-10 |
| Is it Feasible to Use Data Obtained Through a Three-Dimensional Reconstructed Image to Assist in Prostate Targeted Biopsy? (NCT07296510) | Zhejiang University | 2022-01-01 |
| NK Cell Therapy for AML (NCT05256277) | Zhejiang University | 2021-12-28 |
| PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer (NCT04768608) | Zhejiang University | 2021-12-23 |
| Clinical Trial of WBC100 on Advanced Solid Tumor (NCT05100251) | Zhejiang University | 2021-12-17 |
| NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer (NCT05213195) | Zhejiang University | 2021-12-10 |
| CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases (NCT04662294) | Zhejiang University | 2021-11-18 |
| A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection (NCT04981665) | Zhejiang University | 2021-11-08 |
| A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis (NCT05085418) | Zhejiang University | 2021-11-05 |
| A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome (NCT05085431) | Zhejiang University | 2021-11-05 |
| Natural Killer (NK) Cell Therapy for B-Cell Malignancies (NCT05379647) | Zhejiang University | 2021-11-04 |
| Effects of Coffee Consumption on Health Among Adults (NCT03817944) | Zhejiang University | 2021-10-18 |
| A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis (NCT05263817) | Zhejiang University | 2021-10-08 |
| A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma (NCT05085444) | Zhejiang University | 2021-10-08 |
| IMC001 for Clinical Research on Advanced Digestive System Malignancies (NCT05028933) | Zhejiang University | 2021-09-30 |
| SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma (NCT04930315) | Zhejiang University | 2021-09-15 |
| A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus Erythematosus (NCT05030779) | Zhejiang University | 2021-09-10 |
| Registry and Clinical Observation of Children With Diarrhoeal Disease (NCT05052489) | Zhejiang University | 2021-09-01 |
| TAS-102 and Anlotinib in ≥3 Lines mGC (NCT05029102) | Zhejiang University | 2021-09-01 |
| A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma (NCT06277206) | Zhejiang University | 2021-08-04 |
| A Study of CAR-T Cells Targeting GPRC5D in the Treatment of r/r Multiple Myeloma (NCT05016778) | Zhejiang University | 2021-06-08 |
| Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy (NCT04599556) | Zhejiang University | 2021-04-01 |
| 18F-FAPI PET Imaging in Pancreatic Adenocarcinoma (NCT05884463) | Zhejiang University | 2021-04-01 |
| Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation (NCT04838704) | Zhejiang University | 2021-04-01 |
| Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma (NCT04756648) | Zhejiang University | 2021-03-10 |
| Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL (NCT04788472) | Zhejiang University | 2021-03-05 |
| Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions (NCT04790747) | Zhejiang University | 2021-03-01 |
| Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay) (NCT06456801) | Zhejiang University | 2021-03-01 |
| Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC (NCT04653480) | Zhejiang University | 2021-02-01 |
| Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL (NCT04740203) | Zhejiang University | 2021-01-31 |
| LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies (NCT04657965) | Zhejiang University | 2021-01-15 |
| NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia (NCT04658004) | Zhejiang University | 2021-01-15 |
| Neoadjuvant Therapy for Locally Advanced Colon Cancer (NCT04625803) | Zhejiang University | 2021-01-04 |
| Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies (NCT04662788) | Zhejiang University | 2021-01-01 |
| A Study of Humanized BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma (NCT04670055) | Zhejiang University | 2021-01-01 |